|Project Title||Health Outcomes of Interest for Evaluation in the Postlicensure Rapid Immunization Safety Monitoring Program|
Monday, April 16, 2012
This article describes the selection process for a comprehensive list of health outcomes of interest for evaluation in the Food and Drug Administration’s Postlicensure Rapid Immunization Safety Monitoring (PRISM) Program.
- Vaccines, Blood & Biologics
- Devices and Radiologic Health